Comment
. 2007 Oct 20;25(30):4855; author reply 4855-6.
doi: 10.1200/JCO.2007.13.3918.
Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results
- PMID: 17947739
- DOI: 10.1200/JCO.2007.13.3918
Item in Clipboard
Comment
Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results
J Clin Oncol.
.
No abstract available
Comment on
-
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.J Clin Oncol. 2007 Jan 1;25(1):32-42. doi: 10.1200/JCO.2006.06.7405. J Clin Oncol. 2007. PMID: 17194903
Similar articles
-
Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine: the question is still ongoing.J Clin Oncol. 2010 May 10;28(14):e221-2; author reply e223-5. doi: 10.1200/JCO.2009.27.4928. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351322 No abstract available.
-
Clinical pharmacology and pharmacogenetics of gemcitabine.Drug Metab Rev. 2009;41(2):77-88. doi: 10.1080/03602530902741828. Drug Metab Rev. 2009. PMID: 19514966 Review.
-
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.J Clin Oncol. 2007 Jan 1;25(1):32-42. doi: 10.1200/JCO.2006.06.7405. J Clin Oncol. 2007. PMID: 17194903
-
The emerging role of gemcitabine in lung cancer: part I.Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-1. Semin Oncol. 1997. PMID: 9194472 No abstract available.
-
Gemcitabine: preclinical pharmacology and mechanisms of action.Semin Oncol. 1996 Oct;23(5 Suppl 10):3-15. Semin Oncol. 1996. PMID: 8893876 Review.
Cited by
-
Integrating pharmacogenetics into gemcitabine dosing--time for a change?Nat Rev Clin Oncol. 2011 Feb 8;8(7):439-44. doi: 10.1038/nrclinonc.2011.1. Nat Rev Clin Oncol. 2011. PMID: 21304503 Review.
-
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective.Cancer Chemother Pharmacol. 2016 Jul;78(1):1-12. doi: 10.1007/s00280-016-3003-0. Epub 2016 Mar 23. Cancer Chemother Pharmacol. 2016. PMID: 27007129 Free PMC article. Review.
-
Highlights for ESMO 40: celebration review for lifetime achievement awards.ESMO Open. 2016 Feb 17;1(1):e000010. doi: 10.1136/esmoopen-2015-000010. eCollection 2016. ESMO Open. 2016. PMID: 27843584 Free PMC article. Review. No abstract available.
-
Current awareness: pharmacoepidemiology and drug safety.Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):i-xvi. doi: 10.1002/pds.1487. Pharmacoepidemiol Drug Saf. 2008. PMID: 18533281 Free PMC article.
-
CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.Blood Adv. 2018 Mar 13;2(5):462-469. doi: 10.1182/bloodadvances.2017014126. Blood Adv. 2018. PMID: 29490977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
